See more : Texas Capital Bancshares, Inc. (TCBI) Income Statement Analysis – Financial Results
Complete financial analysis of TECON BIOLOGY Co.LTD (002100.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TECON BIOLOGY Co.LTD, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- PC Partner Group Limited (1263.HK) Income Statement Analysis – Financial Results
- Ambipar Participações e Empreendimentos S.A. (AMBP3.SA) Income Statement Analysis – Financial Results
- Hypoport SE (HYPOF) Income Statement Analysis – Financial Results
- Hutchison Telecommunications Hong Kong Holdings Limited (0215.HK) Income Statement Analysis – Financial Results
- Great Boulder Resources Limited (GBR.AX) Income Statement Analysis – Financial Results
TECON BIOLOGY Co.LTD (002100.SZ)
About TECON BIOLOGY Co.LTD
Tecon Biology Co.Ltd engages in the research, development, production, and sale of animal feed in China and internationally. The company offers chicken, pig, ruminant, aquatic, and other feed products; and protein feeds and edible oils, as well as breeds piglets and pigs, and processes and sells meat. It also produces soybean, sunflower, rapeseed, and cottonseed oils and meals. In addition, the company manufactures and sells veterinary biological products. Further, it offers loan, bill acceptance, trade financing, project financing, credit, and other financing guarantees, as well as provides commodity financing supervision services. The company was formerly known as Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. and changed its name to Tecon Biology Co.Ltd in June 2016. Tecon Biology Co.Ltd was founded in 1993 and is based in Urumqi, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 19.03B | 16.73B | 15.74B | 11.99B | 7.48B | 5.27B | 4.63B | 4.44B | 4.17B | 4.01B | 3.72B | 3.33B | 2.98B | 2.37B | 2.07B | 1.07B | 670.65M | 420.40M | 371.28M | 282.29M | 235.55M |
Cost of Revenue | 18.96B | 14.97B | 14.21B | 8.27B | 5.60B | 4.16B | 3.55B | 3.35B | 3.26B | 3.23B | 3.10B | 2.80B | 2.53B | 1.96B | 1.72B | 836.46M | 519.27M | 329.97M | 290.56M | 231.36M | 194.16M |
Gross Profit | 61.29M | 1.76B | 1.54B | 3.72B | 1.88B | 1.11B | 1.08B | 1.09B | 909.49M | 789.32M | 629.07M | 525.98M | 450.21M | 404.96M | 350.27M | 231.94M | 151.39M | 90.43M | 80.72M | 50.93M | 41.39M |
Gross Profit Ratio | 0.32% | 10.50% | 9.77% | 30.99% | 25.09% | 21.04% | 23.40% | 24.52% | 21.82% | 19.66% | 16.89% | 15.81% | 15.09% | 17.09% | 16.88% | 21.71% | 22.57% | 21.51% | 21.74% | 18.04% | 17.57% |
Research & Development | 257.23M | 181.06M | 142.89M | 103.99M | 84.89M | 78.65M | 53.89M | 77.53M | 60.42M | 74.76M | 60.37M | 56.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 398.78M | 125.04M | 433.16M | 328.25M | 142.73M | 102.63M | 83.21M | 95.55M | 115.04M | 74.66M | 62.38M | 59.84M | 41.57M | 34.39M | 109.62M | 70.74M | 58.78M | 23.85M | 25.00M | 13.69M | 11.33M |
Selling & Marketing | 543.06M | 475.21M | 527.45M | 694.33M | 545.82M | 312.94M | 273.82M | 282.58M | 315.12M | 284.05M | 239.50M | 207.52M | 176.15M | 124.68M | 106.53M | 55.37M | 29.97M | 15.98M | 18.05M | 11.00M | 9.26M |
SG&A | 941.84M | 600.25M | 960.61M | 1.02B | 688.55M | 415.57M | 357.03M | 378.12M | 430.16M | 358.71M | 301.88M | 267.35M | 217.72M | 159.07M | 216.15M | 126.11M | 88.74M | 39.84M | 43.06M | 24.69M | 20.59M |
Other Expenses | 308.26M | 326.83M | 424.40M | 559.85M | 342.98M | 1.19M | 2.86M | 45.40M | 32.70M | 14.75M | 10.33M | 14.47M | 10.20M | 11.32M | 6.16M | 4.66M | 11.12M | -1.11M | -220.07K | -101.69K | 311.72K |
Operating Expenses | 1.51B | 1.11B | 1.53B | 1.69B | 1.12B | 695.21M | 617.33M | 659.90M | 625.11M | 506.67M | 430.64M | 368.70M | 283.35M | 247.74M | 217.79M | 127.56M | 89.80M | 40.49M | 43.71M | 25.06M | 20.90M |
Cost & Expenses | 20.47B | 16.08B | 15.73B | 9.96B | 6.72B | 4.86B | 4.16B | 4.01B | 3.88B | 3.73B | 3.53B | 3.17B | 2.82B | 2.21B | 1.94B | 964.02M | 609.06M | 370.46M | 334.27M | 256.42M | 215.06M |
Interest Income | 53.59M | 37.71M | 16.07M | 19.84M | 20.18M | 14.10M | 10.84M | 5.96M | 8.35M | 2.78M | 1.76M | 0.00 | 2.61M | 933.04K | 818.13K | 2.01M | 601.71K | 134.80K | 154.28K | 232.74K | -0.36 |
Interest Expense | 245.54M | 242.99M | 205.99M | 196.30M | 193.10M | 86.06M | 30.49M | 25.46M | 42.84M | 25.31M | 28.00M | 42.32M | 58.20M | 37.71M | 22.89M | 19.85M | 9.68M | 11.22M | 9.38M | 5.79M | 3.79M |
Depreciation & Amortization | 814.03M | 725.68M | 744.29M | 489.26M | 334.15M | 225.47M | 187.66M | 180.50M | 163.83M | 102.99M | 91.20M | 65.28M | 59.10M | 47.06M | 42.50M | 25.59M | 21.27M | 16.45M | 10.44M | 5.94M | 4.95M |
EBITDA | -429.23M | 1.17B | 247.49M | 2.45B | 1.10B | 633.74M | 640.99M | 628.78M | 486.82M | 387.79M | 301.44M | 226.67M | 192.50M | 210.49M | 177.37M | 134.11M | 79.48M | 65.39M | 46.49M | 32.20M | 25.45M |
EBITDA Ratio | -2.26% | 8.21% | 4.52% | 21.06% | 14.94% | 12.37% | 14.13% | 14.77% | 12.64% | 9.66% | 8.74% | 7.70% | 8.58% | 8.82% | 8.67% | 12.60% | 12.63% | 15.59% | 12.52% | 11.41% | 10.80% |
Operating Income | -1.45B | 660.16M | 6.98M | 1.81B | 800.16M | 333.23M | 425.75M | 387.30M | 240.41M | 216.06M | 173.18M | 119.74M | 80.74M | 114.40M | 105.82M | 83.46M | 46.90M | 39.18M | 27.06M | 20.62M | 17.27M |
Operating Income Ratio | -7.60% | 3.95% | 0.04% | 15.08% | 10.70% | 6.32% | 9.20% | 8.71% | 5.77% | 5.38% | 4.65% | 3.60% | 2.71% | 4.83% | 5.10% | 7.81% | 6.99% | 9.32% | 7.29% | 7.30% | 7.33% |
Total Other Income/Expenses | -46.93M | -444.13M | -653.49M | -400.71K | -210.24M | 1.19M | 2.86M | 45.15M | 29.54M | 5.95M | 9.06M | -4.93M | 10.20M | -32.32M | -20.50M | -16.26M | -13.06M | -13.95M | -10.53M | -5.43M | -143.37K |
Income Before Tax | -1.49B | 235.84M | -646.51M | 1.81B | 589.93M | 334.41M | 428.61M | 426.19M | 269.95M | 229.66M | 182.24M | 134.11M | 90.94M | 125.73M | 111.98M | 88.12M | 48.54M | 37.86M | 26.66M | 20.48M | 17.12M |
Income Before Tax Ratio | -7.85% | 1.41% | -4.11% | 15.08% | 7.89% | 6.34% | 9.26% | 9.59% | 6.48% | 5.72% | 4.89% | 4.03% | 3.05% | 5.31% | 5.40% | 8.25% | 7.24% | 9.00% | 7.18% | 7.25% | 7.27% |
Income Tax Expense | 23.46M | 21.70M | 32.01M | 22.43M | -2.46M | 33.36M | 24.83M | 36.31M | 25.14M | 28.02M | 17.33M | 29.97M | 14.14M | 18.11M | 13.37M | 22.99M | 99.74K | -19.12K | 75.17K | 140.42K | -555.41K |
Net Income | -1.36B | 214.15M | -678.52M | 1.72B | 644.49M | 313.73M | 407.15M | 392.54M | 245.79M | 207.63M | 169.80M | 108.01M | 76.89M | 107.43M | 98.45M | 64.87M | 48.34M | 38.18M | 27.47M | 20.14M | 17.60M |
Net Income Ratio | -7.17% | 1.28% | -4.31% | 14.35% | 8.62% | 5.95% | 8.79% | 8.83% | 5.90% | 5.17% | 4.56% | 3.25% | 2.58% | 4.53% | 4.75% | 6.07% | 7.21% | 9.08% | 7.40% | 7.14% | 7.47% |
EPS | -1.01 | 0.16 | -0.62 | 1.61 | 0.61 | 0.33 | 0.42 | 0.41 | 0.27 | 0.27 | 0.21 | 0.14 | 0.10 | 0.14 | 0.14 | 0.11 | 0.07 | 0.12 | 0.06 | 0.04 | 0.04 |
EPS Diluted | -1.01 | 0.16 | -0.62 | 1.60 | 0.61 | 0.33 | 0.42 | 0.41 | 0.27 | 0.27 | 0.21 | 0.14 | 0.10 | 0.14 | 0.14 | 0.11 | 0.07 | 0.12 | 0.06 | 0.04 | 0.04 |
Weighted Avg Shares Out | 1.35B | 1.35B | 1.10B | 1.07B | 1.06B | 950.69M | 963.38M | 957.42M | 910.35M | 872.77M | 808.56M | 771.51M | 768.87M | 754.88M | 723.37M | 657.43M | 657.48M | 330.20M | 509.51M | 509.51M | 509.51M |
Weighted Avg Shares Out (Dil) | 1.35B | 1.35B | 1.10B | 1.08B | 1.06B | 950.69M | 969.40M | 957.42M | 910.35M | 872.77M | 808.56M | 771.51M | 768.87M | 754.88M | 723.37M | 657.43M | 657.48M | 330.20M | 509.51M | 509.51M | 509.51M |
Source: https://incomestatements.info
Category: Stock Reports